Suchen
Assertio Holdings Inc
ASRTZur Watchlist hinzufügen
23.495USD
0.0000.00%
Handelsschluss 07/02, 13:00（ET）Kurse um 15 Minuten verzögert
151.86MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Assertio Holdings Inc Unternehmen
Assertio Holdings, Inc. is a pharmaceutical company offering differentiated products to patients. The Company has built its commercial portfolio through the acquisition or licensing of approved products. Its commercial capabilities include marketing through both a sales force and an omni-channel promotion model, market access through payor contracting, and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, and CAMBIA (diclofenac potassium for oral solution). INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID). Otrexup is a once weekly single-dose auto-injector containing methotrexate.
Assertio Holdings Inc Informationen
BörsenkürzelASRT
Name des UnternehmensAssertio Holdings Inc
IPO-datumFeb 12, 1997
CEOReisenauer (Mark L)
Anzahl der mitarbeiter58
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 12
Addresse100 S. Saunders Road
StadtLAKE FOREST
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl60045
Telefon12244197106
Websitehttps://www.assertiotx.com/
BörsenkürzelASRT
IPO-datumFeb 12, 1997
CEOReisenauer (Mark L)
Führungskräfte von Assertio Holdings Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Sam Schlessinger
Mr. Sam Schlessinger
Executive Vice President, General Counsel
Executive Vice President, General Counsel
13.35K
+22.04%
Mr. David Matthew Stark
Mr. David Matthew Stark
Independent Director
Independent Director
9.03K
+53.71%
Mr. Mark L. Reisenauer
Mr. Mark L. Reisenauer
Chief Executive Officer, Director
Chief Executive Officer, Director
1.20K
--
Ms. Heather L. Mason
Ms. Heather L. Mason
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. William T. Mckee
Mr. William T. Mckee
Independent Director
Independent Director
--
--
Mr. Paul Schwichtenberg
Mr. Paul Schwichtenberg
President, Chief Operating Officer
President, Chief Operating Officer
--
-100.00%
Mr. Ajay Patel
Mr. Ajay Patel
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
-100.00%
Mr. Sravan K. Emany
Mr. Sravan K. Emany
Independent Director
Independent Director
--
--
Mr. Sigurd C. (Sig) Kirk
Mr. Sigurd C. (Sig) Kirk
Independent Director
Independent Director
--
--
Ms. Mary E Pietryga
Ms. Mary E Pietryga
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Sam Schlessinger
Mr. Sam Schlessinger
Executive Vice President, General Counsel
Executive Vice President, General Counsel
13.35K
+22.04%
Mr. David Matthew Stark
Mr. David Matthew Stark
Independent Director
Independent Director
9.03K
+53.71%
Mr. Mark L. Reisenauer
Mr. Mark L. Reisenauer
Chief Executive Officer, Director
Chief Executive Officer, Director
1.20K
--
Ms. Heather L. Mason
Ms. Heather L. Mason
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. William T. Mckee
Mr. William T. Mckee
Independent Director
Independent Director
--
--
Mr. Paul Schwichtenberg
Mr. Paul Schwichtenberg
President, Chief Operating Officer
President, Chief Operating Officer
--
-100.00%
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Assertio Holdings Inc?
Die fünf größten Anteilseigner von Assertio Holdings Inc sind: Mr. Sam Schlessinger
Wie viele Institutionen halten Anteile an Assertio Holdings Inc (ASRT)?
Mit Stand vom 2026Q1 halten 213 Institutionen Anteile an Assertio Holdings Inc, mit einem Gesamtmarktwert von etwa 2.20M, was 34.20% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -70665.00 gestiegen.
Was ist die größte Einnahmequelle von Assertio Holdings Inc?
Am 2026Q1 erzielte das Geschäft mit ROLVEDON für Assertio Holdings Inc den höchsten Umsatz in Höhe von 68.22M, was 57.47% des Gesamtumsatzes entspricht.